INDEVUS PHARMACEUTICALS INC 4
4 · INDEVUS PHARMACEUTICALS INC · Filed Oct 4, 2004
Insider Transaction Report
Form 4
SANDAGE BOBBY W PHD
Executive Vice President
Transactions
- Award
Common Stock, $.001 par value
2004-10-01$2.38/sh+10,000$23,750→ 68,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-10-01$2.38/sh−10,000$23,750→ 452,500 totalExercise: $2.38From: 2004-10-01Exp: 2010-04-05→ Common Stock, $.001 par value (10,000 underlying) - Sale
Common Stock, $.001 par value
2004-10-01$7.13/sh−10,000$71,300→ 58,039 total - Sale
Common Stock, $.001 par value
2004-10-01$7.13/sh−15,000$106,950→ 58,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-10-01$2.38/sh−15,000$35,625→ 437,500 totalExercise: $2.38From: 2004-10-01Exp: 2010-04-05→ Common Stock, $.001 par value (15,000 underlying) - Award
Common Stock, $.001 par value
2004-10-01$2.38/sh+15,000$35,625→ 73,039 total
Footnotes (7)
- [F1]Represents exercise of stock options granted pursuant to the Company's 1994 Long-term Incentive Plan.
- [F2]Represents exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
- [F3]Represents shares acquired pursuant to exercise of stock options granted pursuant to the Company's 1994 Long-term Incentive Plan.
- [F4]Represents sale of common stock acquired pursuant to the Company's 1994 Long-term Incentive Plan.
- [F5]Represents shares acquired pursuant to exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
- [F6]Represenst sale of stock acquired pursuant to the Company's 2000 Stock Option Plan.
- [F7]Represents sale of securities pursuant to a 10b 5-1 Plan.